Tolerance induction with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with a 10-year follow-up

BACKGROUND: Immunosuppressive therapy after life-saving kidney transplantation increases the risk of infection, cardiovascular diseases, metabolic diseases, and cancer. To date, four centers (three in the USA and one in South Korea) have reported clinical tolerance trials in kidney transplantation....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuanchuan, Yang, Cheng, Hu, Linkun, Wei, Zheng, Tang, Qunye, Chen, Bing, Ji, Yuan, Xu, Ming, Zeng, Zhaochong, Rong, Ruiming, Zhu, Tongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723571/
https://www.ncbi.nlm.nih.gov/pubmed/33313123
http://dx.doi.org/10.21037/atm-20-2502a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723571/
https://www.ncbi.nlm.nih.gov/pubmed/33313123
http://dx.doi.org/10.21037/atm-20-2502a

Ejemplares similares